Valproate (VPA) is a short-chain fatty acid with HDAC inhibitor activity that is widely prescribed as one of the first-line medications for epilepsy and bipolar disorders [10], [11], [12], [13]. The gene discussed is HDAC9; the disease is bipolar disorder.